Nazerai, L., Willis, S. C., Yankilevich, P., Di Leo, L., Bosisio, F. M., Frias, A., . . . De Zio, D. (2022). Thiopurine 6TG treatment increases tumor immunogenicity and response to immune checkpoint blockade.
Citación estilo ChicagoNazerai, Loulieta, et al. Thiopurine 6TG Treatment Increases Tumor Immunogenicity and Response to Immune Checkpoint Blockade. 2022.
Cita MLANazerai, Loulieta, et al. Thiopurine 6TG Treatment Increases Tumor Immunogenicity and Response to Immune Checkpoint Blockade. 2022.
Precaución: Estas citas no son 100% exactas.